Audentes Homepage2019-08-05T22:12:00-07:00


Audentes Therapeutics is a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases.

Courageous Patients

We see the patient community as our partners, collaborators, and teachers. We believe that their perspectives should be integrated throughout the drug development process from initiation of a clinical program to its completion and beyond.

Learn More

Our People

We take pride in our efforts to harness the transformative potential of AAV-based genetic medicines to improve the lives of patients suffering from serious rare neuromuscular diseases.


Media & Social Updates

Latest News


Audentes is different – we take time to understand our patient communities and weave that knowledge with our scientific insights to develop transformative therapies. Follow us on Facebook to share with us, stay updated and learn more.


What bold things can you expect from us next? Keep track of company announcements, by following us on Twitter!

Learn more about what we’re doing to become the leader in the development and commercialization of innovative genetic medicines to treat serious rare neuromuscular diseases, the people who make it great and the exciting job opportunities available by following us on LinkedIn.